Contrary to the wild-type ROS1, oncogenic fusion composed of the C’-terminal activation loop of ROS1 has already been discovered in various neoplasms, while there are several earlier reports in the case of GBM [12,18,20,21,22,23]. The gene discussed is ROS1; the disease is glioblastoma.